Seasonal Influenza Vaccines 2025/2026
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Region | Northern Ireland |
| Procedure | selective |
| OCID | ocds-h6vhtk-050ba9 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Seqirus UK Ltd | · | · | active |
description
This contract is for the procurement of a range of Seasonal Influenza Vaccines for the population of Northern Ireland
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 1 May 2025 | Contract award notice (F03) | Earlier regulations | 018527-2025 |
more from Regional Business Services Organisation, Procurement and Logistics Service
- Pre-Market Engagement - CAWT PEACEPLUS EASY Project: Early Intervention Support for Children, Young People and Families presenting with Neurodevelopmental Needs (SHSCT Area) · 20 Jul 2026
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · £1,800,000,000 · 3 Jul 2026
- Seasonal Influenza Vaccines 2026/2027 · 21 May 2026
- Pre-Market Engagement - CAWT PEACEPLUS Community Connections and Wellbeing project (CCWP) – Delivery of Psychosocial Activities and Community Supports (WHSCT and SHSCT Areas) · 15 May 2026
- Agency Workers – Medical and Dental · £345,000,000 · 28 Apr 2026
- Pre-Market Engagement - CAWT PEACEPLUS Healthier Futures Project - Community-Based Early Intervention Health Improvement Programmes (WHSCT & SHSCT Areas) · 27 Apr 2026
- Total Cellular Pathology Solution - 2805386 · £65,000,000 · 4 Mar 2026
- Cellular Pahology Staining For the NHSCT and SHSCT · 2 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.